The immunohistochemical staining of the xenograft sections revealed that Smarcd1 upregulation lowered the positive rate of Ki-67, which referred to enhanced cancer cell proliferation (Fig. 2 i and j). This evidence concerns the gene SMARCD1 and cancer.